![Anne Chun Longo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anne Chun Longo
Director Ejecutivo en PharmatrophiX, Inc. .
Perfil
Anne Chun Longo is currently the Chief Executive Officer at PharmatrophiX, Inc. She started this position in 2006.
She completed her undergraduate degree at Stanford University.
Cargos activos de Anne Chun Longo
Empresas | Cargo | Inicio |
---|---|---|
PharmatrophiX, Inc.
![]() PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Director Ejecutivo | 01/01/2006 |
Formación de Anne Chun Longo.
Stanford University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
PharmatrophiX, Inc.
![]() PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Health Technology |
- Bolsa de valores
- Insiders
- Anne Chun Longo